# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011079
Filing Date
2024-08-06
Accepted
2024-08-06 16:05:49
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rigl-20240630x10q.htm iXBRL | 10-Q | 2327800
2 | EX-10.1 | rigl-20240630xex10d1.htm | EX-10.1 | 177297
3 | EX-10.2 | rigl-20240630xex10d2.htm | EX-10.2 | 144569
4 | EX-31.1 | rigl-20240630xex31d1.htm | EX-31.1 | 15896
5 | EX-31.2 | rigl-20240630xex31d2.htm | EX-31.2 | 16782
6 | EX-32.1 | rigl-20240630xex32d1.htm | EX-32.1 | 9073
7 | GRAPHIC | rigl-20240630x10q006.jpg | GRAPHIC | 88487
| Complete submission text file | 0001558370-24-011079.txt |  | 9393670

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | EX-101.SCH | rigl-20240630.xsd | EX-101.SCH | 56771
9 | EX-101.CAL | rigl-20240630_cal.xml | EX-101.CAL | 61207
10 | EX-101.DEF | rigl-20240630_def.xml | EX-101.DEF | 222027
11 | EX-101.LAB | rigl-20240630_lab.xml | EX-101.LAB | 478147
12 | EX-101.PRE | rigl-20240630_pre.xml | EX-101.PRE | 358129
82 | EXTRACTED XBRL INSTANCE DOCUMENT | rigl-20240630x10q_htm.xml | XML | 1548136

Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 241179126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)